Home > Insider Trading > Filing (0001209191-11-042498)

Filing Details

Accession Number:: 0001209191-11-042498
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-04 17:12:00
Reporting Period:: 2011-08-02

Filing Date:: 2011-08-04
Accepted Time:: 2011-08-04 17:12:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1136148	Atlas Venture Fund Vi Lp	C/O Atlas Venture 25 First Street, Suite 303 Cambridge MA 02141	No	No	Yes	No
1143182	Atlas Venture Entrepreneurs Fund Vi Lp	C/O Atlas Venture 25 First Street, Suite 303 Cambridge MA 02141	No	No	Yes	No
1292358	Atlas Venture Fund Vi Gmbh & Co Kg	C/O Atlas Venture 25 First Street, Suite 303 Cambridge MA 02141	No	No	Yes	No
1292360	Atlas Venture Associates Vi, Inc	C/O Atlas Venture 25 First Street, Suite 303 Cambridge MA 02141	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-02	1,577,819	$0.00	1,577,819	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	179,740	$0.00	1,757,559	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	387,034	$9.00	2,144,593	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	7,086	$9.00	2,151,679	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	11,834	$9.00	2,163,513	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	352,576	$9.00	2,516,089	No	4	P	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	6,456	$9.00	2,522,545	No	4	P	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	10,782	$9.00	2,533,327	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	P	Indirect	See FN
No	4	P	Indirect	See FN
No	4	P	Indirect	See FN

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-08-02	1,577,819	$0.00	1,577,819	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2011-08-02	179,740	$0.00	179,740	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	387,034	$9.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	7,086	$9.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	11,834	$9.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,859,851	Indirect	See FN

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
Includes 46,003 shares held of record by Atlas Venture Entrepreneurs' Fund VI, L.P. ("AVE"), 27,544 shares held of record by Atlas Fund VI GmbH & Co. KG ("GmbH") and 1,504,272 shares held by Atlas Venture Fund VI, L.P. ("Venture"). These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
Includes 5,240 shares held of record by AVE, 3,137 shares held of record by GmbH and 171,363 shares held by Venture. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
Securities held in the name of Venture. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
Securities held in the name of GmbH. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
Securities held in the name of AVE. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
Includes 83,379 shares held of record by AVE, 49,923 shares held of record by GmbH and 2,726,549 shares held by Venture. These shares are owned directly by AVE, GmbH and Venture. Atlas Venture Associates VI, L.P. disclaims beneficial ownership as to such shares except to the extent of its proportionate pecuniary interest therein and each of AVE, GmbH and Venture disclaim beneficial ownership to such shares other than those shares held directly by them.
These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.